Skip to main content
OpenTrials

Clinical trial condition

Bladder Neoplasms

Explore clinical trials studying Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Bladder Neoplasms trial results

Completed

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

NCT00315237

Conditions
Bladder Cancer, Bladder Neoplasms, Carcinoma, +15 more
Locations
  • Local Institution Calgary, Alberta, Canada
  • Local Institution Edmonton, Alberta, Canada
  • Local Institution Vancouver, British Columbia, Canada
  • Local Institution Victoria, British Columbia, Canada
View Trial Details
Completed

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

NCT00077688

Conditions
Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • University of Maryland Medical Center/Greenbaum Cancer Center Baltimore, Maryland, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Completed

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

NCT00491114

Conditions
Bladder Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Como, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Genova, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy
View Trial Details

Related conditions